What to Do When Muscle Relaxers Don’t Work

Muscle relaxers are built for short-term relief, and the evidence behind them reflects that. Large reviews consistently show that these drugs reduce acute pain for roughly two weeks but do not improve disability or produce meaningful long-term outcomes. When you reach the point where your prescription feels useless, the problem is rarely that you need a higher dose or a different brand of the same drug. It usually means the source of your pain requires a fundamentally different strategy.

Why Muscle Relaxers Stop Working (or Never Did)

The first thing worth understanding is how narrow the window of proven benefit actually is. A meta-analysis covering 31 trials and over 6,500 participants found that muscle relaxants reduced acute low back pain for two weeks or less, but there was no significant reduction in pain-related disability even during that short window.¹ An earlier systematic review of 15 trials told essentially the same story: short-term pain relief, no data on what happens after that. These drugs were never designed for months of use. If you have been taking one for weeks or longer and the pain persists, you are past the point where the evidence supports that approach.

A second, more fundamental reason muscle relaxers fail is that the muscle spasm they target is sometimes a symptom rather than a cause. In chronic back and neck pain, muscles often tighten as a protective reflex around an unstable spinal segment. A review in the Journal of Craniovertebral Junction and Spine described this directly: muscle spasm and pain are secondary to spinal instability, and muscle contraction is a stabilization response. When the underlying structural issue drives the spasm, muscle relaxants and pain medications often fail to provide long-term relief.² If your body is bracing because a joint or disc is unstable, chemically forcing those muscles to relax does not fix the instability. The spasm returns because the signal telling those muscles to guard is still firing.

The Tolerance Trap and the Risks of Pushing Higher

When a muscle relaxer seems to lose its punch, the instinct is to take more. This is where things get genuinely risky. Tolerance to drugs that act on the central nervous system develops through well-documented receptor changes. In animal studies, chronic exposure to the neuromuscular blocker d-tubocurarine led to a measurable increase in the drug concentration needed to achieve the same effect, alongside a proliferation of acetylcholine receptors at the muscle junction.³ In plain terms, the body builds more targets for the drug to block, so you need more drug to achieve the same muscle relaxation. For benzodiazepine-class relaxants like diazepam, tolerance to the sedative and muscle-relaxant effects develops relatively quickly, even while tolerance to some other effects may not develop at all.⁴ So you lose the therapeutic benefit while still being exposed to side effects.

Escalating the dose also intensifies those side effects. A review of the three most commonly prescribed muscle relaxants for acute low back pain found that the main adverse events involved the central nervous system: drowsiness, sedation, fatigue, and dizziness.⁵ With cyclobenzaprine, those sedative effects were dose-related, meaning a higher dose produced proportionally more drowsiness. The same review flagged the growing abuse potential of carisoprodol (Soma), which is metabolized into meprobamate, a controlled substance. If your muscle relaxer has stopped helping, asking for a stronger prescription may trade a pain problem for a dependence problem.

The picture gets darker when muscle relaxers are combined with opioids, which happens more than you might expect. A large population-based cohort study found that people using both opioids and skeletal muscle relaxants at the same time had elevated risk of opioid overdose, especially when the daily opioid dose reached 50 mg or more, or when benzodiazepines were also in the mix.⁶ If you are on opioids alongside a muscle relaxer that is not working, that combination carries real danger with diminishing returns.

Genetics Can Make Certain Muscle Relaxers Ineffective From the Start

Some people metabolize muscle relaxants in unusual ways because of inherited genetic variations. This has been studied most extensively with succinylcholine, a neuromuscular blocker used in surgery, but the principle applies broadly to drugs broken down by the same enzyme families. Over sixty known variations in the butyrylcholinesterase gene can cause the enzyme responsible for breaking down certain muscle relaxants to work too slowly or too quickly. In patients carrying the most common mutation (the Kalow variant), muscle relaxation from succinylcholine lasted up to four minutes longer than in people with the normal gene.⁷ The enzyme dysfunction can go in the other direction too, potentially clearing the drug before it has time to work. If you have tried multiple muscle relaxers and none of them seem to do anything, this is a conversation worth having with your doctor. Pharmacogenomic testing is available and can sometimes explain an otherwise baffling non-response.

Medications That Work Through Different Pathways

When a muscle relaxer fails, the next medication is not necessarily another muscle relaxer. Several drug classes target chronic musculoskeletal pain through entirely different mechanisms, and the evidence behind some of them is stronger than for muscle relaxants used long-term.

Duloxetine, an SNRI antidepressant, has accumulated substantial evidence for chronic musculoskeletal pain. A systematic review and meta-analysis found that duloxetine produced statistically significant improvements in 24-hour average pain, physical function, quality of life, and patient global impressions compared to placebo, with no difference in serious adverse events between the groups.⁸ Duloxetine works by increasing serotonin and norepinephrine in the descending pain-inhibition pathways of the spinal cord, which is a completely different target than the sedation-based approach of traditional muscle relaxers. It also tends to improve mood, which matters because chronic pain and depression reinforce each other. This is not a drug you take as needed for a bad day; it builds up over weeks. But for persistent musculoskeletal pain that muscle relaxers cannot touch, the evidence supports it.

For conditions like fibromyalgia, where widespread muscle pain is the defining symptom, pregabalin (Lyrica) has shown benefit at daily doses of 300 to 600 mg. A systematic review and meta-analysis found pregabalin at 450 mg per day was effective compared to placebo, though the number needed to treat was about seven, meaning roughly one in seven patients experienced meaningful improvement beyond what a sugar pill would provide.⁹ That is a modest effect, and about one in four patients stopped treatment due to side effects like dizziness, drowsiness, and weight gain. Pregabalin calms overexcited nerve signaling rather than relaxing muscle tissue directly, which is why it can succeed where muscle relaxers have failed. Gabapentin works similarly but had less data available at the time of the review.

Hands-On Treatments for Stubborn Trigger Points

If your pain is localized to specific knotted, tender spots in a muscle, those are likely myofascial trigger points. Muscle relaxers are a blunt instrument for this problem. Two targeted alternatives have a growing evidence base: dry needling and trigger point injections.

Dry needling involves inserting a thin needle directly into the trigger point without injecting any medication. Trigger point injection does the same thing but delivers a small amount of local anesthetic or other substance. A systematic review comparing the two for neck pain found that trigger point injection reduced pain intensity more than dry needling alone, with a large effect size. However, neither treatment was clearly better for disability, pressure sensitivity, range of motion, or depression.¹⁰ A separate randomized trial comparing dry needling to magnesium infiltration in trigger points found that both improved pain, mental health, and physical health at one and three months, with no significant differences between the two approaches.¹¹ The improvements faded by six months, which means these are treatments that may need to be repeated or combined with exercise to maintain the benefit. The overall evidence is still considered preliminary, with a systematic review on temporomandibular myofascial pain noting that most studies had methodological limitations and that larger, longer trials are needed.¹²

For muscle spasms and cramps that resist everything else, botulinum toxin (Botox) is a more aggressive option. You probably associate it with cosmetic procedures, but it was originally developed for muscle disorders. When injected into a muscle, it blocks the nerve signal that triggers contraction, producing targeted relaxation that lasts months. Beyond that mechanical effect, research suggests botulinum toxin has direct analgesic properties independent of its muscle-relaxing action, possibly by blocking pain-signaling molecules from nerve endings.¹³ A double-blind, placebo-controlled study in patients with muscle cramps caused by diabetic neuropathy, cramps that had already failed to respond to standard medications, found that botulinum toxin injection significantly improved all outcome measures compared to placebo.¹⁴ This is not a first-line treatment for garden-variety back pain, but for focal, treatment-resistant spasms and cramps, it offers something that oral muscle relaxers cannot: targeted, sustained relaxation precisely where the problem is.

Multidisciplinary Rehabilitation Programs

If your pain has lasted months and no single treatment has worked, the strongest evidence points toward programs that combine physical therapy, psychological support, and functional restoration into one coordinated approach. This is not a vague suggestion to “try a few things.” The data on structured multidisciplinary rehabilitation is some of the most robust in chronic pain research.

A Cochrane systematic review pooling data from dozens of randomized trials found moderate to low quality evidence that multidisciplinary biopsychosocial rehabilitation reduced both pain and disability more than usual care in the long term. Compared to physical treatment alone, the advantage was even larger for disability outcomes. Patients receiving multidisciplinary care were also more likely to return to work.¹⁵ An earlier systematic review reached a similar conclusion with stronger language: intensive multidisciplinary biopsychosocial rehabilitation with functional restoration provided strong evidence of improved function compared to non-multidisciplinary treatments, and moderate evidence of reduced pain compared to usual care.¹⁶

What does this look like in practice? A recent randomized feasibility study of a structured multidisciplinary pain program found significant reductions in pain intensity at four months with a medium-sized effect, along with improvements in quality of life.¹⁷ These programs typically include supervised exercise, education about pain neuroscience (so you understand why you hurt and are not afraid to move), cognitive-behavioral strategies for managing the emotional weight of chronic pain, and often workplace or ergonomic adjustments. The critical ingredient seems to be addressing the physical, psychological, and functional dimensions together rather than in isolated silos.

The reason this matters so much when muscle relaxers fail is that chronic pain changes how the nervous system processes signals. The original injury may have healed, but the brain and spinal cord can stay stuck in a hypersensitive state called central sensitization, where normal sensations are amplified into pain. A muscle relaxer does nothing for this. Biofeedback, one component sometimes included in multidisciplinary programs, has been shown to influence central sensitization by modulating autonomic nervous system activity and reducing the hypervigilance to pain stimuli that keeps the cycle going.¹⁸ Learning to downregulate your own nervous system is a skill, and it addresses a pain mechanism that no pill in a bottle can reach.

Sleep and Magnesium as Overlooked Amplifiers

Poor sleep and chronic muscle pain have a circular relationship that muscle relaxers ironically can make worse. Many muscle relaxers cause drowsiness, which patients sometimes welcome, but the sedation they produce is not the same as restorative sleep. If you are sleeping poorly, your pain threshold drops, muscle recovery slows, and inflammatory markers rise. Magnesium deficiency may be part of this picture. Research has linked low magnesium status to sleep disorders and to the inflammatory stress associated with conditions like diabetes and cardiovascular disease.¹⁹ Magnesium plays a role in muscle contraction and relaxation at a cellular level, and many people do not get enough of it through diet alone. Correcting a deficiency is unlikely to replace medical treatment, but it is a low-risk intervention that removes one possible contributor. Your doctor can check serum magnesium with a simple blood test.

Sleep hygiene changes, if you have not already made them, are worth taking seriously at this stage. Consistent sleep and wake times, a cool and dark bedroom, and limiting screen exposure before bed are well-established strategies. If the muscle relaxer you were prescribed was doubling as a sleep aid, talk to your doctor about transitioning to something that actually improves sleep architecture rather than just knocking you out, as restoring genuine deep sleep can have a measurable effect on how much pain you experience the next day.

How to Talk to Your Doctor About All of This

The conversation about failed muscle relaxers can be tricky. Doctors sometimes default to refilling a prescription because it is simpler than rethinking the whole approach, and patients sometimes assume the drug should keep working if they just give it more time. If you have been on a muscle relaxer for more than a few weeks without improvement, bring that up directly. Say that the medication is not controlling your pain and ask whether it is time to investigate the underlying cause more thoroughly. Imaging, a referral to physical therapy, or an evaluation for a multidisciplinary program are all reasonable next steps.

Be specific about what “not working” means. Are you still having spasms? Is the pain constant rather than episodic? Has your function improved even if the pain has not? These distinctions help your doctor determine whether the problem is the medication, the diagnosis, or both. If your pain is localized and reproducible by pressing on a specific spot, mention it, because that points toward trigger point therapies. If your pain is widespread and accompanied by fatigue, poor sleep, and brain fog, that picture looks more like fibromyalgia or central sensitization, which require entirely different treatment strategies. The more precisely you describe the failure, the faster you and your doctor can pivot to something that actually works.